Booze and Pancreatic Cancer Risk; From ‘Hospice’ to ‘Hope’; Gen Z-ers Skip Screening

A new study showed a “dose response risk relationship” between alcohol consumption and pancreatic cancer. (International Journal of Alcohol and Drug Research)

Brain tumors diagnosed in 11 nurses at Newton-Wellesley Hospital in suburban Boston were not caused by any exposures to chemicals, radiation, or anything else at their workplace, an independent report concluded. (NBC10 Boston)

The FDA approved 131 drugs in 2025, exceeding the 10-year average of 123 since 2016. (GlobalData)

Suggesting a potential new approach to treating prostate cancer, preclinical research has shown that bioengineered nanoparticles directly killed prostate cancer cells and at the same time enhanced anti-tumor immunity. (Weill Cornell Medicine)

Food insecurity among children with blood cancers was associated with longer hospital stays and an increased risk of readmission. (Pediatric Blood Cancer)

Soligenix has decided to terminate its cutaneous T-cell lymphoma therapy development program following a negative phase III trial of the company’s photodynamic therapy HyBryte. (Fierce Biotech)

Patients with stage IV (metastatic) cancers are living longer than ever, as the search for cures continues. (New York Times)

For a 39-year-old woman with newly diagnosed metastatic colon cancer, a liver transplant turned “hospice into hope.” (CBS News)

Subtle changes in heart structure and function, or cardiac remodeling, may identify individuals at increased risk of developing cancer. (UCLA Health)

Publishing company Taylor & Francis is investigating a pair of decade-old research articles about glyphosate (Roundup) weedkiller, published in Critical Reviews in Toxicology, in response to allegations the articles were ghostwritten by employees of maker Monsanto. (Retraction Watch)

The American Society of Clinical Oncology updated its clinical guideline on multiple myeloma to recommend teclistamab (Tecvayli) and daratumumab (Darzalex) combination therapy and ciltacabtagene autoleucel (Carvykti) CAR T-cell therapy as preferred treatment options for relapsed/refractory disease. (ASCO Daily News)

Despite failure to meet the primary endpoint in a randomized trial, clinical development of the investigational pancreatic cancer treatment ELI-002 7P will continue, Elicio Therapeutics announced, citing an imbalance in complete surgical resection as an explanation for the findings.

A new study will examine whether acupuncture can help relieve chemotherapy-induced neuropathy. (UTHealth Houston)

Colonoscopy remains the best screening option for colorectal cancer, stool-based tests are reasonable alternatives, and blood tests require caution, according to the American Gastroenterological Association.

Uptake of the human papillomavirus vaccine has reduced the risk of cervical cancer death before age 30 in England “to effectively zero.” (Cancer Research UK)

More than a third of Americans, including half of Gen Zers, skip cancer screenings because of fear or confusion. (Mesothelioma.com)